Cencora Increases Quarterly Dividend From $0.60 To $0.66 Per Share; Announces Corporate Realignment To Separate Out Specialty Solutions

On November 3, 2026, the Company declared a quarterly dividend of $0.66 per common share, a 10 percent increase in its quarterly dividend rate from $0.60 per common share. The quarterly dividend of $0.66 per common share is payable November 30, 2026, to stockholders of record at the close of business on November 13, 2026.

To better support its specialty provider and manufacturer partners and capitalize on the strength of its end-to-end specialty solutions, Cencora is bringing together its specialty businesses under one leader, Richard Tremonte. These businesses will be reported under the Specialty Pharmaceutical and Provider Services segment and consist of:

Specialty distribution and GPO services supporting access and contracting to thousands of community-based specialists across the U.S.
Oncology and retina MSO platforms providing administrative, clinical trial and research and data and analytics services to physicians.
Global specialty logistics supporting clinical trials and complex therapy distribution with 140 logistics sites across over 50 countries.
Multinational third-party logistics (3PL) supporting 23 million lines across 15 countries in North America and Europe.
Commercialization services providing hub-and-spoke solutions in Canada and global pharmacovigilance, regulatory affairs and market access solutions.
Cencora’s remaining U.S. businesses and its smaller European wholesale pharmaceutical distribution business will be organized under the Pharmaceutical Distribution and Services segment. To continue leveraging its scale and supply chain efficiency while recognizing the distinct needs of its customers, Cencora’s remaining U.S. businesses will be organized under the following verticals:

Health Systems, led byMatthew Glucksmann: Providing comprehensive solutions to meet the needs of leading hospitals, health systems and government facilities including:
Integrated model for wholesale and specialty distribution
Holistic health system pharmacy support services, including specialty GPO services; and
Unit-dose repackaging
Retail Pharmacy and Alternate Care, led by Tim Cernohous: Serving pharmacies at the heart of community health and ensuring patient access to pharmaceuticals.
Cencora’s European wholesale pharmaceutical distribution business will be led by Juan Guerra.